Bloodstream Infection Testing Market Players:
- Abbott Laboratories
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- biomerieux SA
- Bruker Corporation
- Danaher Corporation
- DiaSorin S.p.A
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
- T2 Biosystems, Inc.
- Accelerate Diagnostics, Inc.
- F. Hoffmann-La Roche Ltd
The major players in the bloodstream infection testing market are offering a detailed portfolio of blood test-related products. These companies introduced advanced technologies that enable detailed visualization of blood test procedures.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of bloodstream infection testing is estimated at USD 6.41 billion.
The global bloodstream infection testing market size was more than USD 6.08 billion in 2025 and is anticipated to witness a CAGR of over 6.1%, crossing USD 10.99 billion revenue by 2035.
North America bloodstream infection testing market will secure over 34% share by 2035, driven by the rapid growth in the geriatric population and the presence of major key players investing in bloodstream infection testing devices.
Key players in the market include Abbott Laboratories, biomerieux SA, Bruker Corporation, Danaher Corporation, DiaSorin S.p.A, Siemens Healthineers AG, Thermo Fisher Scientific Inc., T2 Biosystems, Inc., Accelerate Diagnostics, Inc., F. Hoffmann-La Roche Ltd.
